Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (191-200 of 497) with videos related to

Pageof 50
Sort By:
Clinical Breast Cancer|January 15, 2017
Evaluation of Local Oncologic Safety in Nipple-Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched StudyRoberto Agresti, Marco Sandri, Massimiliano Gennaro, et al.
Anticancer Research|April 9, 2013
A review on biomarkers for prediction of treatment outcome in gastric cancerFilippo Pietrantonio, Filippo De Braud, Valentina Da Prat, et al.
Oncology|June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moonFilippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progressionFrancesco Panzuto, Letizia Boninsegna, Nicola Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rareTommaso De Pas, Giuseppe Pelosi, Filippo de Braud, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2021
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumorsFelipe K Hurtado, Filippo de Braud, Javier De Castro Carpeño, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Breast Cancer Research and Treatment|June 16, 2017
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective studyClaudio Vernieri, Monica Milano, Alessia Mennitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes failsCristiana Sessa, Filippo De Braud, Antonella Perotti, et al.
Pageof 50

Showing results (191-200 of 497) with videos related to

Sort By:
Pageof 50
Clinical Breast Cancer|January 15, 2017
Evaluation of Local Oncologic Safety in Nipple-Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched StudyRoberto Agresti, Marco Sandri, Massimiliano Gennaro, et al.
Anticancer Research|April 9, 2013
A review on biomarkers for prediction of treatment outcome in gastric cancerFilippo Pietrantonio, Filippo De Braud, Valentina Da Prat, et al.
Oncology|June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moonFilippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progressionFrancesco Panzuto, Letizia Boninsegna, Nicola Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rareTommaso De Pas, Giuseppe Pelosi, Filippo de Braud, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2021
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumorsFelipe K Hurtado, Filippo de Braud, Javier De Castro Carpeño, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Breast Cancer Research and Treatment|June 16, 2017
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective studyClaudio Vernieri, Monica Milano, Alessia Mennitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes failsCristiana Sessa, Filippo De Braud, Antonella Perotti, et al.
Pageof 50